HK Stock Market Move | LAOPU GOLD(06181) rises over 8% to hit a new high. The company was recently included in the Hong Kong Stock Connect list. The peak season for jewelry sales is approaching.
Lao Pu Gold (06181) rose over 7%, hitting a high of 125.9 Hong Kong dollars, setting a new record high since listing. As of the time of writing, it rose 8.35%, closing at 125.8 Hong Kong dollars, with a turnover of 29.1495 million Hong Kong dollars.
LAOPU GOLD (06181) rose more than 7%, reaching a high of 125.9 Hong Kong dollars, hitting a new high since its listing. As of the time of writing, it has risen 8.35% to 125.8 Hong Kong dollars, with a transaction amount of 29.1495 million Hong Kong dollars.
On the news front, on September 10, the list of Hong Kong Stock Connect constituents officially took effect, with LAOPU GOLD being included in the list. The expected improvement in the company's liquidity is expected to further drive up the stock price. In addition, the company recently released its interim financial report, showing rapid growth in revenue and profits, with net profit increasing by nearly 200% year-on-year.
Debang Securities pointed out that LAOPU GOLD's differentiated product positioning, comprehensive and high-quality product matrix within a subdivided track, continuous improvement in brand strength, sustained release of brand effectiveness, and strong channel expansion capabilities are expected to further improve the company's performance. Looking ahead to 24H2, the upcoming peak season for gold and jewelry sales in September and October, with stable gold prices, the high-end jewelry scarcity of LAOPU GOLD is promising.
Related Articles

Miwei Biology-B (02493) starts its IPO today, with cornerstone investors Junshi Bio, Guilin Sanjin Pharmaceutical and Wuxi Bio subscribing to US$53 million worth of shares.

Subscription of A-shares | Zhongke Instrument (920186.BJ) starts subscription, focusing on the research and development of clean vacuum and ultra-high vacuum technology.

YIDU TECH (02158) profit pre-announcement: Net profit for the fiscal year 2026 is expected to be between 55 million and 70 million yuan. "AI orders" are strong.
Miwei Biology-B (02493) starts its IPO today, with cornerstone investors Junshi Bio, Guilin Sanjin Pharmaceutical and Wuxi Bio subscribing to US$53 million worth of shares.

Subscription of A-shares | Zhongke Instrument (920186.BJ) starts subscription, focusing on the research and development of clean vacuum and ultra-high vacuum technology.

YIDU TECH (02158) profit pre-announcement: Net profit for the fiscal year 2026 is expected to be between 55 million and 70 million yuan. "AI orders" are strong.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


